FDAFDA · Food and drugs·Recall number D-0313-2025
Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1
Published April 16, 2025 · Recall initiated: March 7, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- SOFOSBUVIR AND VELPATASVIR
- Manufacturer
- ASEGUA THERAPEUTICS LLC
- Distributor
- US Nationwide
- Lot
- Lot# 24ASV002UA, Exp Date: 6/30/2028
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.